Crispr is still on the rise and trading within it's rising channel.
It looks like it has completed a 5th wave and is due for a correction. There is major support around $73.00 which is also the 61.8% fib level.
This may present a nice buying opportunity if it drops to around $73.00 and that support holds up. I think gene editing and genetic engineering will continue to have positive momentum until at least November.
Disclaimer: This is not financial advice. Do your own research and due diligence. Good Luck!
It looks like it has completed a 5th wave and is due for a correction. There is major support around $73.00 which is also the 61.8% fib level.
This may present a nice buying opportunity if it drops to around $73.00 and that support holds up. I think gene editing and genetic engineering will continue to have positive momentum until at least November.
Disclaimer: This is not financial advice. Do your own research and due diligence. Good Luck!